As shown in Figure 3, the AL138831.2-related gene were indeed enriched in tumour-related networks, including “DNA repair”, “negative regulation of NF-κB signalling”, “glycogen metabolic process” and “ZNF proteins”, indicating that the activation of these pathways may promote higher mortality risk in patients with high-risk scores. This evidence concerns the gene NFKB1 and neoplasm.